Improving HPV vaccine communication in pharmacies
Part of Cancer, Immune system & allergy, Infections clinical trials.
This study looks at whether training pharmacy staff in communication and vaccination workflows can improve HPV vaccine recommendations and uptake. If you are a parent or guardian of a child aged 9–17 who has not yet completed the HPV vaccine series, you may be eligible to participate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You live in one of the 50 U.S. states or Washington, D.C.
- You are a parent or guardian of a child aged 9 to 17.
- Your child has not yet completed the full HPV vaccine series (all recommended doses).
- You can read and understand English.
- You are willing to complete a survey about your experiences.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program designed to help primary care practices increase HPV vaccination rates among adolescents aged 9 to 12 who haven't yet been vaccinated. It aims to find out if providing practices with resources and support can lead to more kids getting the HPV vaccine.
This trial tests if sharing stories can help parents decide to get their child the HPV vaccine. It is for parents of children ages 9 to 12 who have not yet started the HPV shot series.
This study tests an educational program to help people in Denver who have not yet started the HPV vaccine (or haven’t finished it) complete the vaccine series. It may help families understand the vaccine and follow through with completing the recommended doses.
This trial tests a program to help community health centers recommend and boost HPV vaccination rates among Latino adolescents aged 11-12. It aims to support health care providers and staff with education and resources.
This trial asks mothers or female guardians who have some concerns about the HPV vaccine to share their stories. The goal is to create messages that help other parents make informed decisions about the vaccine for their children.
This study tests whether real-time reminders and guidance help families stay on track with the HPV vaccine for children who are 11–12 years old. It’s a “feasibility” study, meaning it focuses on whether the approach is practical and acceptable.
Hear when a new Human Papillomavirus-Related Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.